Trebananib
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Trebananib, covering 2015-07-02 to 2022-06-07. Get the full timeline:
Most recent: Clinical Trial Update: Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer [Phase 2]